Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Stock Information for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Loading
Please wait while we load your information from QuoteMedia.